Kyle LaHucik, an associate editor covering the gamut of the biotech industry for Endpoints News, has taken on the role of senior reporter to cover venture capital funding, M&A, IPOs and company creation for the financing and business development side of biopharma.
Prior to joining Endpoints, LaHucik was a staff writer at FierceMarkets. Before that, he was a reporter at Mergermarket and interned at Bloomberg, Bloomberg BNA and MLex Market Insight. He was also a newsletter writer at Missouri Business Alert.
He also worked as a public life reporter and education reporter at Columbia Missourian.
LaHucik has a bachelor’s degree in journalism from the University of Missouri-Columbia.
You can congratulate LaHucik on X/Twitter.
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…
Members of the CoinDesk editorial team have sent a letter to the CEO of its…